Owens & Minor, Inc. (NYSE:OMI) Files An 8-K Regulation FD Disclosure
Regulation FD Disclosure
Owens& Minor, Inc. (the “Company”) has prepared an investor presentation with information about the Company and intends to use the presentation as part of an investor conference on March 12, 2019. A copy of the presentation is attached hereto as Exhibit 99.1 and is also available atwww.owens-minor.comunder theInvestor Relations Events& Presentationssection.
The information in Exhibit 99.1 is being furnished to Item 7.01 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Financial Statements and Exhibits.
OWENS & MINOR INC/VA/ Exhibit
EX-99.1 2 finalomiforbarclaysgloba.htm EXHIBIT 99.1 finalomiforbarclaysgloba Barclays Global Healthcare Conference March 12,…
To view the full exhibit click
About Owens & Minor, Inc. (NYSE:OMI)
Owens & Minor, Inc. is a global healthcare services company. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices in the United States and Europe. The Company operates in two segments: Domestic and International. The Domestic segment includes all functions relating to its role as a medical supply logistics company providing distribution; kitting, including Medical Action Industries Inc., and logistics services to healthcare providers and manufacturers in the United States. The International segment consists of Movianto Group and ArcRoyal. The Company serves customers with a service portfolio that covers procurement, inventory management, delivery and sourcing for the healthcare market. With fully developed networks in the United States and Europe, it serves hospitals, integrated healthcare systems, group purchasing organizations, the United States federal government and pharmaceuticals.